AR123150A1 - Composiciones para modular el empalme - Google Patents
Composiciones para modular el empalmeInfo
- Publication number
- AR123150A1 AR123150A1 ARP210102177A ARP210102177A AR123150A1 AR 123150 A1 AR123150 A1 AR 123150A1 AR P210102177 A ARP210102177 A AR P210102177A AR P210102177 A ARP210102177 A AR P210102177A AR 123150 A1 AR123150 A1 AR 123150A1
- Authority
- AR
- Argentina
- Prior art keywords
- unsubstituted
- substituted
- independently hydrogen
- independently
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063061742P | 2020-08-05 | 2020-08-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR123150A1 true AR123150A1 (es) | 2022-11-02 |
Family
ID=80117649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP210102177A AR123150A1 (es) | 2020-08-05 | 2021-08-04 | Composiciones para modular el empalme |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230331718A1 (https=) |
| EP (1) | EP4192454B1 (https=) |
| JP (1) | JP2023538524A (https=) |
| KR (1) | KR20230048106A (https=) |
| CN (1) | CN116171153B (https=) |
| AR (1) | AR123150A1 (https=) |
| AU (1) | AU2021320763A1 (https=) |
| CA (1) | CA3188104A1 (https=) |
| IL (1) | IL300352A (https=) |
| MX (1) | MX2023001558A (https=) |
| TW (1) | TW202216697A (https=) |
| UY (1) | UY39368A (https=) |
| WO (1) | WO2022031838A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020163248A1 (en) | 2019-02-04 | 2020-08-13 | Skyhawk Therapeutics, Inc. | Methods and compositions for modulating splicing |
| EP3920915A4 (en) * | 2019-02-05 | 2022-10-05 | Skyhawk Therapeutics, Inc. | METHODS AND COMPOSITIONS FOR MODULATING SPLICE |
| CN114126613A (zh) | 2019-02-05 | 2022-03-01 | 斯基霍克疗法公司 | 用于调节剪接的方法和组合物 |
| WO2020163544A1 (en) | 2019-02-06 | 2020-08-13 | Skyhawk Therapeutics, Inc. | Methods and compositions for modulating splicing |
| CN113661162A (zh) | 2019-02-06 | 2021-11-16 | 斯基霍克疗法公司 | 用于调节剪接的方法和组合物 |
| GB202106871D0 (en) * | 2021-05-13 | 2021-06-30 | Addex Pharmaceuticals Sa | Novel compounds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2579949T3 (es) | 2010-02-05 | 2016-08-17 | Heptares Therapeutics Limited | Derivados de 1,2,4-triazin-4-amina |
| WO2019028440A1 (en) | 2017-08-04 | 2019-02-07 | Skyhawk Therapeutics, Inc. | METHODS AND COMPOSITIONS FOR MODULATING SPLICING |
| MX2020009957A (es) | 2018-03-27 | 2021-01-15 | Ptc Therapeutics Inc | Compuestos para el tratamiento de enfermedad de hungtinton. |
| CN112272666A (zh) | 2018-04-10 | 2021-01-26 | 斯基霍克疗法公司 | 用于治疗癌症的化合物 |
| WO2020163248A1 (en) * | 2019-02-04 | 2020-08-13 | Skyhawk Therapeutics, Inc. | Methods and compositions for modulating splicing |
| EP3920915A4 (en) * | 2019-02-05 | 2022-10-05 | Skyhawk Therapeutics, Inc. | METHODS AND COMPOSITIONS FOR MODULATING SPLICE |
| EP3920918A4 (en) * | 2019-02-05 | 2022-11-16 | Skyhawk Therapeutics, Inc. | METHODS AND COMPOSITIONS FOR MODULATION OF SPLICING |
| WO2022031998A2 (en) | 2020-08-05 | 2022-02-10 | Skyhawk Therapeutics, Inc. | Process for the preparation of intermediates useful in the preparation of compounds that modulate splicing |
-
2021
- 2021-08-04 EP EP21852740.6A patent/EP4192454B1/en active Active
- 2021-08-04 AU AU2021320763A patent/AU2021320763A1/en active Pending
- 2021-08-04 UY UY0001039368A patent/UY39368A/es not_active Application Discontinuation
- 2021-08-04 KR KR1020237007640A patent/KR20230048106A/ko active Pending
- 2021-08-04 JP JP2023508065A patent/JP2023538524A/ja active Pending
- 2021-08-04 AR ARP210102177A patent/AR123150A1/es unknown
- 2021-08-04 TW TW110128712A patent/TW202216697A/zh unknown
- 2021-08-04 IL IL300352A patent/IL300352A/en unknown
- 2021-08-04 CA CA3188104A patent/CA3188104A1/en active Pending
- 2021-08-04 WO PCT/US2021/044528 patent/WO2022031838A1/en not_active Ceased
- 2021-08-04 MX MX2023001558A patent/MX2023001558A/es unknown
- 2021-08-04 CN CN202180062419.8A patent/CN116171153B/zh active Active
-
2023
- 2023-01-31 US US18/162,085 patent/US20230331718A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL300352A (en) | 2023-04-01 |
| CN116171153A (zh) | 2023-05-26 |
| US20230331718A1 (en) | 2023-10-19 |
| WO2022031838A1 (en) | 2022-02-10 |
| CN116171153B (zh) | 2025-11-21 |
| EP4192454A4 (en) | 2024-09-11 |
| EP4192454A1 (en) | 2023-06-14 |
| TW202216697A (zh) | 2022-05-01 |
| CA3188104A1 (en) | 2022-02-10 |
| UY39368A (es) | 2022-01-31 |
| JP2023538524A (ja) | 2023-09-08 |
| KR20230048106A (ko) | 2023-04-10 |
| MX2023001558A (es) | 2023-04-26 |
| AU2021320763A1 (en) | 2023-03-30 |
| EP4192454B1 (en) | 2026-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR123150A1 (es) | Composiciones para modular el empalme | |
| AR126854A1 (es) | Compuestos macrocíclicos para el tratamiento de cáncer | |
| AR119494A1 (es) | DERIVADOS DE 6,7-DIHIDRO-5H-PIRIDO[2,3-c]PIRIDAZIN-8-ILO, COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN Y SUS USOS COMO AGENTES PROAPOPTÓTICOS | |
| AR119770A1 (es) | Proceso de elaboración de moduladores de cftr | |
| MX2022012676A (es) | Compuestos y metodos para modular el empalme. | |
| AR094314A1 (es) | Inhibidores de fosfatidilinositol 3-cinasa | |
| CO6231002A2 (es) | Compuestos utiles como ligandos para tomar imagenes de inervacion cardiaca | |
| ECSP12011756A (es) | Nuevos maitansinoides y el uso de dichos maitansinoides | |
| AR113296A1 (es) | Pirrolidinonas y un proceso para preparar las mismas | |
| NZ505776A (en) | Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors | |
| AR131006A1 (es) | Compuestos novedosos | |
| AR130984A1 (es) | Compuestos novedosos | |
| AR101815A1 (es) | Compuestos y composiciones como inhibidores de quinasa | |
| NI201000049A (es) | Método para producir 2'-desoxi-5-azacitidina (decitabina) | |
| AR102480A1 (es) | ALCOHOLES TRIFLUOROMETÍLICOS COMO MODULADORES DE RORgt | |
| AR090376A1 (es) | Compuestos herbicidas | |
| CL2023001301A1 (es) | 1,4-diazepanonas bicíclicas y sus usos terapéuticos. | |
| AR066955A1 (es) | Derivados de 7- alquinil -1,8- naftiridonas, su preparacion y su aplicacion en terapeutica | |
| AR095059A1 (es) | Compuestos herbicidas | |
| CL2023002783A1 (es) | Compuestos para regular inmunidad entrenada y sus métodos de uso | |
| AR132456A1 (es) | Compuestos novedosos | |
| AR132377A1 (es) | Compuestos novedosos | |
| AR123582A1 (es) | Triazinonas inhibidores de la producción de inflamasoma de nlrp3 | |
| AR119341A1 (es) | Profármacos de moduladores del receptor de nmda | |
| AR122141A1 (es) | Inhibidor de trka |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |